2021 Q4 Form 10-K Financial Statement

#000185173422000194 Filed on April 12, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $6.483M $4.361M $4.230M
YoY Change 53.26% -73.87% 14.82%
Cost Of Revenue $3.376M $10.42M $2.117M
YoY Change 59.47% 39.38% 8.56%
Gross Profit $3.107M $11.07M $2.113M
YoY Change 47.04% 20.18% 21.86%
Gross Profit Margin 47.93% 253.91% 49.95%
Selling, General & Admin $2.513M $2.638M $2.847M
YoY Change -11.73% -79.07% -36.31%
% of Gross Profit 80.88% 23.82% 134.74%
Research & Development $10.00K $9.000K
YoY Change -99.73%
% of Gross Profit 0.32% 0.08%
Depreciation & Amortization $55.00K $210.0K $50.00K
YoY Change 10.0% 16.02% 35.14%
% of Gross Profit 1.77% 1.9% 2.37%
Operating Expenses $2.523M $4.590M $2.853M
YoY Change -11.57% -80.44% -48.8%
Operating Profit $584.0K -$229.0K -$740.0K
YoY Change -178.92% -96.62% -80.72%
Interest Expense $1.643M $28.00K $4.935M
YoY Change -66.71% -79.1% 612.12%
% of Operating Profit 281.34%
Other Income/Expense, Net $4.000K -$19.91M $2.000K
YoY Change 100.0% 4674.1%
Pretax Income $2.416M $5.150M $4.197M
YoY Change -42.44% -171.66% -233.45%
Income Tax $342.0K $342.0K
% Of Pretax Income 14.16% 6.64%
Net Earnings $2.074M -$20.14M $4.197M
YoY Change -50.58% 180.19% -233.45%
Net Earnings / Revenue 31.99% -461.75% 99.22%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share $9.439K -$0.10 $22.10K
COMMON SHARES
Basic Shares Outstanding 210.4M 195.1M
Diluted Shares Outstanding 195.1M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $866.0K $866.0K $1.422M
YoY Change -39.1% -39.1% -41.91%
Cash & Equivalents $866.0K $1.422M
Short-Term Investments
Other Short-Term Assets $755.0K $755.0K $450.0K
YoY Change 67.78% 67.78% -38.27%
Inventory $5.005M $5.005M $1.593M
Prepaid Expenses
Receivables $1.368M $1.368M $1.258M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.994M $7.994M $4.723M
YoY Change 69.26% 69.26% -15.83%
LONG-TERM ASSETS
Property, Plant & Equipment $431.0K $1.186M $531.0K
YoY Change -18.83% -31.48% -75.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $68.00K $68.00K $71.00K
YoY Change -4.23% -4.23% 0.0%
Total Long-Term Assets $1.254M $1.254M $1.802M
YoY Change -30.41% -30.41% -19.45%
TOTAL ASSETS
Total Short-Term Assets $7.994M $7.994M $4.723M
Total Long-Term Assets $1.254M $1.254M $1.802M
Total Assets $9.248M $9.248M $6.525M
YoY Change 41.73% 41.73% -16.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.476M $2.476M $629.0K
YoY Change 293.64% -1.94% -75.0%
Accrued Expenses $1.579M $1.579M $456.0K
YoY Change 246.27% 246.27% 7.04%
Deferred Revenue $238.0K $268.0K
YoY Change -11.19%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.400M
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $5.534M $5.534M $10.74M
YoY Change -48.49% -48.49% 49.69%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K $150.0K $1.016M
YoY Change -85.24% -85.24%
Other Long-Term Liabilities $433.0K $433.0K $762.0K
YoY Change -43.18% -43.18% -37.44%
Total Long-Term Liabilities $583.0K $583.0K $1.778M
YoY Change -67.21% -67.21% 45.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.534M $5.534M $10.74M
Total Long-Term Liabilities $583.0K $583.0K $1.778M
Total Liabilities $6.117M $6.117M $12.52M
YoY Change -51.15% -51.15% 49.15%
SHAREHOLDERS EQUITY
Retained Earnings -$4.855M -$9.663M
YoY Change -49.76%
Common Stock $211.0K $190.0K
YoY Change 11.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.131M $3.131M -$5.996M
YoY Change
Total Liabilities & Shareholders Equity $9.248M $9.248M $6.525M
YoY Change 41.73% 41.73% -16.86%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $2.074M -$20.14M $4.197M
YoY Change -50.58% 180.19% -233.45%
Depreciation, Depletion And Amortization $55.00K $210.0K $50.00K
YoY Change 10.0% 16.02% 35.14%
Cash From Operating Activities -$367.0K -$1.347M $229.0K
YoY Change -260.26% -58.85% -115.15%
INVESTING ACTIVITIES
Capital Expenditures -$37.00K $110.0K -$16.00K
YoY Change 131.25% -34.91% -92.23%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$37.00K -$110.0K -$16.00K
YoY Change 131.25% -34.91% -92.23%
FINANCING ACTIVITIES
Cash Dividend Paid $883.0K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $901.0K 0.000
YoY Change -62.71%
NET CHANGE
Cash From Operating Activities -367.0K -$1.347M 229.0K
Cash From Investing Activities -37.00K -$110.0K -16.00K
Cash From Financing Activities 0.000 $901.0K 0.000
Net Change In Cash -404.0K -$556.0K 213.0K
YoY Change -289.67% -45.81% -112.4%
FREE CASH FLOW
Cash From Operating Activities -$367.0K -$1.347M $229.0K
Capital Expenditures -$37.00K $110.0K -$16.00K
Free Cash Flow -$330.0K -$1.457M $245.0K
YoY Change -234.69% -57.67% -118.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Irvine, California
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4068000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
210890930
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
210890930
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189907526
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189907526
CY2020Q4 us-gaap Inventory Net
InventoryNet
1600000 USD
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021Q4 us-gaap Cash
Cash
866000 USD
CY2020Q4 us-gaap Cash
Cash
1422000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1368000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1258000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
5005000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1593000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
755000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
450000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7994000 USD
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1650000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
238000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
268000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5534000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10743000 USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
150000 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1016000 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1400000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1200000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71000 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1254000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1802000 USD
CY2021Q4 us-gaap Assets
Assets
9248000 USD
CY2020Q4 us-gaap Assets
Assets
6525000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2525000 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
899000 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4444000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
4723000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
431000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
531000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
755000 USD
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
329000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
456000 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
433000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
762000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
583000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1778000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
6117000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
12521000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
211000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
190000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7775000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3477000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4855000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9663000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3131000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5996000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9248000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6525000 USD
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21496000 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
16692000 USD
CY2021 chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
10423000 USD
CY2020 chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
7478000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8750000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10873000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1734000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1733000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3378000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
20931000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
23462000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
565000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-6770000 USD
CY2021 us-gaap Interest Expense
InterestExpense
34000 USD
CY2020 us-gaap Interest Expense
InterestExpense
134000 USD
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3545000 USD
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-300000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1060000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Other Income
OtherIncome
14000 USD
CY2020 us-gaap Other Income
OtherIncome
17000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4585000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-417000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5150000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7187000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
342000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4808000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-7187000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
203589531
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189844867
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237686875
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189844867
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-547000 USD
CY2020 chuc Adjustments To Additional Paid In Capital Reclassification Of Liabilities To Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfLiabilitiesToEquity
1638000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1650000 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1750000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-7187000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5996000 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
770000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
3000 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
552000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4808000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3131000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4808000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-7187000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
109000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
60000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
210000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
181000 USD
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3545000 USD
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-300000 USD
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
445000 USD
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
423000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
552000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
3072000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1060000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
CY2021 us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-3289000 USD
CY2020 us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
4036000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
219000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
400000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3412000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
77000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
305000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-279000 USD
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3000 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-0 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1553000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
325000 USD
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-30000 USD
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
177000 USD
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-456000 USD
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-426000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1347000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2448000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1026000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1422000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3273000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
110000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
169000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-169000 USD
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000 USD
CY2020 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
184000 USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2416000 USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1400000 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 USD
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
883000 USD
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
-0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
901000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2416000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-556000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
866000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1422000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
150000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021 us-gaap Stock Issued1
StockIssued1
770000 USD
CY2020 us-gaap Stock Issued1
StockIssued1
0 USD
CY2021 chuc Dividends Accrual
DividendsAccrual
0 USD
CY2020 chuc Dividends Accrual
DividendsAccrual
1650000 USD
CY2021 chuc Reclassification Of Liability Awards To Equity
ReclassificationOfLiabilityAwardsToEquity
0 USD
CY2020 chuc Reclassification Of Liability Awards To Equity
ReclassificationOfLiabilityAwardsToEquity
1638000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
600000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4800000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3100000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
5000000.0 USD
CY2021Q4 us-gaap Cash
Cash
900000 USD
CY2020Q4 us-gaap Cash
Cash
1400000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3000000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3517000
CY2021 chuc Number Of Subsidiaries
NumberOfSubsidiaries
2 pure
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3545000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4144000 USD
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-300000 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4444000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
109000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
355000 USD
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
156000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
179000 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189844867
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
899000 USD
CY2019Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
27500000 USD
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.44313
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1104000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
994000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
673000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
463000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
431000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
531000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
210000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
181000 USD
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
168309
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2476000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
629000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
902000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1420000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
342000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
348000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
476000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4068000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2525000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2021Q4 chuc Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
150000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
150000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4808000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7187000 USD
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3545000 USD
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1263000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7187000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
203589531
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1912544
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
32016491
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237686875
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189844867
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45380000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
103484000
CY2020Q2 chuc Share Exchange Value Per Share
ShareExchangeValuePerShare
0.44313
CY2021Q2 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
1736501
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.44313
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.853
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3000000.0 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8013000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.54
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.44
CY2020 chuc Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P10Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
560000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.63
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7503000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.54
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
80000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.44
CY2021 chuc Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P10Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
460000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.44
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7123000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5376000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.57
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2021Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
1500000
CY2021Q2 chuc Shares Restricted Stock Award Subject To Annual Forfeiture
SharesRestrictedStockAwardSubjectToAnnualForfeiture
750000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
552000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3072000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.54
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2019Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
9000000.0
CY2019Q2 us-gaap Share Price
SharePrice
0.32
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2900000 USD
CY2018Q4 chuc Common Stock Awards Unvested
CommonStockAwardsUnvested
7100000
CY2018Q4 chuc Common Stock Awards Fair Value Per Share
CommonStockAwardsFairValuePerShare
0.32
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
566000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
597000 USD
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
0 USD
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
0 USD
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
566000 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
597000 USD
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
CY2021 us-gaap Lease Cost
LeaseCost
566000 USD
CY2020 us-gaap Lease Cost
LeaseCost
597000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
456000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
423000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M17D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M26D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2064000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
399000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
275000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
206000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
880000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
118000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
762000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
110000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
232000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
342000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
342000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 chuc Deferred Tax Asset Bad Debt
DeferredTaxAssetBadDebt
47000 USD
CY2020Q4 chuc Deferred Tax Asset Bad Debt
DeferredTaxAssetBadDebt
119000 USD
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
43000 USD
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
48000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
222000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
16000 USD
CY2021Q4 chuc Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
208000 USD
CY2020Q4 chuc Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
341000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
255000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
201000 USD
CY2021Q4 chuc Deferred Tax Assets Transaction Costs
DeferredTaxAssetsTransactionCosts
0 USD
CY2020Q4 chuc Deferred Tax Assets Transaction Costs
DeferredTaxAssetsTransactionCosts
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1224000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1835000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-9000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-3000 USD
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
1000 USD
CY2021Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
56000 USD
CY2020Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
287000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
32000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2851000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
206000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
336000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
18000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
56000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
224000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
359000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1840000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2459000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1840000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2459000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.000 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.033 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.051 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.101 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.035 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.043 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.001 pure
CY2021 chuc Effective Income Tax Rate Reconciliation Net Operating Loss Adjustment
EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustment
0.031 pure
CY2020 chuc Effective Income Tax Rate Reconciliation Net Operating Loss Adjustment
EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustment
0.000 pure
CY2021 chuc Effective Income Tax Rate Reconciliation Derivatives Percent
EffectiveIncomeTaxRateReconciliationDerivativesPercent
-0.111 pure
CY2020 chuc Effective Income Tax Rate Reconciliation Derivatives Percent
EffectiveIncomeTaxRateReconciliationDerivativesPercent
-0.007 pure
CY2021 chuc Effective Income Tax Rate Reconciliation Return To Provision Adjustment Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent
-0.022 pure
CY2020 chuc Effective Income Tax Rate Reconciliation Return To Provision Adjustment Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentPercent
-0.198 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.013 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.120 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.020 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.066 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
32000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD

Files In Submission

Name View Source Status
0001851734-22-000194-index-headers.html Edgar Link pending
0001851734-22-000194-index.html Edgar Link pending
0001851734-22-000194.txt Edgar Link pending
0001851734-22-000194-xbrl.zip Edgar Link pending
chuc-20211231.xsd Edgar Link pending
chuc-20211231_cal.xml Edgar Link unprocessable
chuc-20211231_def.xml Edgar Link unprocessable
chuc-20211231_lab.xml Edgar Link unprocessable
chuc-20211231_pre.xml Edgar Link unprocessable
chuc20211231_10k.htm Edgar Link pending
chuc20211231_10k_htm.xml Edgar Link completed
ex_344745.htm Edgar Link pending
ex_349485.htm Edgar Link pending
ex_349486.htm Edgar Link pending
ex_349487.htm Edgar Link pending
ex_349488.htm Edgar Link pending
ex_353485.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending